.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Updates on the Treatment of Malignant Melanoma

EP. 1: Treatment Approaches for Resectable Melanoma

February 24th 2015

EP. 2: Frontline Therapy for BRAF-Mutated Unresectable Melanoma

February 24th 2015

EP. 3: Immunotherapy in BRAF Wild-Type Advanced Melanoma

February 24th 2015

EP. 4: Treatment Duration for PD-1 Inhibitors in Melanoma

February 24th 2015

EP. 5: Managing Toxicity of Immunotherapy in Melanoma

February 24th 2015

EP. 6: Measuring Response to Immunotherapy in Melanoma

February 24th 2015

EP. 7: Multidisciplinary Care for Malignant Melanoma

February 24th 2015

EP. 8: Combination Therapies for Metastatic Melanoma

February 24th 2015

EP. 9: Earlier Use of Checkpoint Inhibitors in Melanoma

February 24th 2015

EP. 10: Adjuvant Immunotherapy for Melanoma

February 24th 2015

EP. 11: Emerging Therapies for Malignant Melanoma

February 24th 2015

EP. 12: Closing Comments: Updates in Malignant Melanoma

February 24th 2015